Original Research
Published on 07 Jan 2025
Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1475884
- 7,537 views
- 7 citations


